General Information
Drug ID
DR00320
Drug Name
Ceftizoxime
Synonyms
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)-2Z-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxyamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-carbonsaeure-7-(Z)-(O-methyloxim); (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2,3-didehydropenam-2-carboxylic acid; Cefizox (TN); Ceftix; Ceftizoxima; Ceftizoxima[INN-Spanish]; Ceftizoxime (INN); Ceftizoxime Monosodium Salt; Ceftizoxime [INN:BAN]; Ceftizoximum; Ceftizoximum [INN-Latin]; Eposerin; FK-749; FK749; FR 13749; FR-13479; FR-13749; SK&F 88373-2; SKF-88373; Syn-7-(2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid
Drug Type
Small molecular drug
Indication Gram-positive & negative bacteria infections [ICD11: 1A00-1H0Z] Approved [1]
Therapeutic Class
Antibiotics
Structure
3D MOL 2D MOL
Formula
C13H13N5O5S2
Canonical SMILES
CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=CCS3)C(=O)O
InChI
InChI=1S/C13H13N5O5S2/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22)/b17-7-/t8-,11-/m1/s1
InChIKey
NNULBSISHYWZJU-LLKWHZGFSA-N
CAS Number
CAS 68401-81-0
Pharmaceutical Properties Molecular Weight 383.4 Topological Polar Surface Area 201
Heavy Atom Count 25 Rotatable Bond Count 5
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 10
XLogP
0
PubChem CID
6533629
PubChem SID
103174922 , 114606946 , 11641637 , 124766423 , 131323579 , 134222601 , 134337748 , 135009953 , 137006383 , 140396425 , 160870913 , 160964629 , 162178763 , 170505879 , 175268604 , 179150929 , 223678791 , 226423279 , 249865495 , 251912547 , 251916656 , 252817575 , 43181664 , 46505647 , 48415732 , 49847130 , 50050951 , 50236104 , 51091962 , 57370867 , 602886 , 7978886 , 87256558 , 9107
ChEBI ID
CHEBI:553473
TTD Drug ID
D0Y7BD
DT(s) Transporting This Drug MRP4 Transporter Info Multidrug resistance-associated protein 4 Substrate [2]
OAT1 Transporter Info Organic anion transporter 1 Substrate [3]
OAT3 Transporter Info Organic anion transporter 3 Substrate [4]
Drug-Transporter Activity Data
Drug-Transporter Activity Data MRP4 Transporter Info Km = 18 microM Human embryonic kidney cells (HEK293)-MRP4 [2]
References
1 Ceftizoxime was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Oral availability of cefadroxil depends on ABCC3 and ABCC4. Drug Metab Dispos. 2012 Mar;40(3):515-21.
3 FDA Drug Development and Drug Interactions
4 Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol. 2005 Oct 1;70(7):1104-13.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.